跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARNUITY ELLIPTA fluticasone furoate 50 microgram powder for inhalation dry powder inhaler - TGA Drug Approval Details
Approvals
/
TGA
/
ARNUITY ELLIPTA fluticasone furoate 50 microgram powder for inhalation dry powder inhaler
Approved
STANDARD
ARNUITY ELLIPTA fluticasone furoate 50 microgram powder for inhalation dry powder inhaler
GlaxoSmithKline Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
0d91cc768286adc4
Company
GlaxoSmithKline Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
0d91cc768286adc4
Product Name
ARNUITY ELLIPTA fluticasone furoate 50 microgram powder for inhalation dry powder inhaler
Artg Id
300141
Artg Name
ARNUITY ELLIPTA fluticasone furoate 50 microgram powder for inhalation dry powder inhaler
Sponsor
GlaxoSmithKline Australia Pty Ltd
Company Detail Path
/organization/glaxosmithkline-australia-pty-ltd
Artg Date
2019-03-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
0d91cc768286adc4
Type
Standard
Back to TGA Approvals
